The Patent Finder
AP

Acura Pharmaceuticals, Inc.

First filing 2003
OverviewNotableFeesChangesFamiliesPatent listSources & methods

13 patents currently held

5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in May 2029. from the record

Of the 5 now held by other companies, 5 name Acura Pharmacueticals Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
May 2029
Next term end
5
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 11 to 15, 2027 · next Feb 11
  • 1 fee due Jul 2, 2027
    The maintenance fee for Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient (US 11,857,629) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse (US 10,610,497) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026

What they patent

The 4 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 12,740,948Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
In force
 · High confidence
In forceHigh confidence
US 9,757,466Methods and Compositions for Deterring Abuse
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 10,155,044Methods and Compositions for Deterring Abuse
In force
 · High confidence
In forceHigh confidence
US 8,901,113Methods and Compositions for Deterring Abuse
In force
 · High confidence
In forceHigh confidence
US 9,101,636Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
In force
 · High confidence
In forceHigh confidence
US 11,857,629Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
In force
 · High confidence
In forceHigh confidence
US 12,773,454Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
In force
 · High confidence
In forceHigh confidence
US 10,610,497Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
In force
 · High confidence
In forceHigh confidence
US 11,197,837Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
In force
 · High confidence
In forceHigh confidence
US 11,723,885Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
In force
 · High confidence
In forceHigh confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 5 patents in force now held by others · 17 patents ended · 1 application pending · 12 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited